Cross-sectional Investigational Study to Evaluate the Sensitivity, Specificity, and Utility of the MedMira Inc. Multiplo® Complete Syphilis (TP/nTP) Antibody Test (POCT) to Diagnose Infectious Syphilis in Participants Attending the Sexual Health Clinic in Ottawa, Ontario.

Launched by MEDMIRA LABORATORIES INC. · May 30, 2024

Keywords

ClinConnect Summary

This clinical trial is looking to evaluate a new test called the Multiplo Complete Syphilis Antibody Test to see how well it can diagnose syphilis in people visiting a sexual health clinic in Ottawa. The test uses a simple finger-prick method to collect a small sample of blood right at the clinic, making it easier and quicker for patients to get results.

To take part in the study, individuals need to be at least 16 years old and able to give their consent. They should be visiting the clinic for syphilis testing as part of their healthcare plan, which could include follow-up appointments after a syphilis diagnosis. Those who are intoxicated, extremely distressed, or confused cannot participate. This trial is not yet open for recruitment, but it aims to improve how syphilis is diagnosed, helping ensure that patients receive the care they need efficiently.

Gender

All

Eligibility criteria

• Inclusion Criteria:
• • Able to provide consent
• • Patients Requiring Syphilis testing as part of care plan
• • Patients attending Clinic for follow up appointments following diagnosis with syphilis infection.
• • Patients who have had other STIs in the past, or being suspected of having other STIs are not excluded as long as testing for syphilis is part of provided care
• • Minimum 16 years of age
• Exclusion Criteria:
• • Unable to provide informed consent due to possible intoxication and/or with extreme distress or confused
• • Patients below the age of 16 years.